Discontinued — last reported Q1 '19
Synopsys Share Repurchase Program, Remaining Authorized, Amount remained flat by 0.0% to $194.30M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $194.30M to $194.30M.
A high remaining balance indicates significant capacity for future buybacks, while a low balance suggests the program may need renewal or that capital is being deployed elsewhere.
This represents the remaining dollar value of shares that the company is authorized to repurchase from the open market u...
Common among mature public companies; peers typically disclose this in the equity or treasury stock notes.
other_stock_repurchase_program_remaining_authorized_repu_889179| Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $325.00M | $750.00M | $500.00M | $242.70M | $1.10B | $794.30M | $494.30M | $194.30M | $194.30M | $194.30M | $194.30M | $194.30M | $194.30M | $194.30M |
| QoQ Change | — | +130.8% | -33.3% | -51.5% | +353.2% | -27.8% | -37.8% | -60.7% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | -25.3% | +46.7% | +58.9% | +103.7% | -82.3% | -75.5% | -60.7% | +0.0% | +0.0% | +0.0% | +0.0% |